Omeros (OMER) Return on Sales Growth (3y) (2013 - 2025)

Omeros (OMER) Return on Sales Growth (3y) (2013 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 0.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -76.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 8.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -1.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 3.00
10 Omeros 1.24 Bn 1.24 Bn 27.73 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 0.00
Mar 31, 2025 -1.00
Jun 30, 2022 3.00
Mar 31, 2022 2.00
Dec 31, 2021 -3.00
Sep 30, 2021 38.00
Jun 30, 2021 67.00
Mar 31, 2021 20.00
Dec 31, 2020 -8.00
Sep 30, 2020 4.00
Jun 30, 2020 3.00
Mar 31, 2020 5.00
Dec 31, 2019 -2.00
Sep 30, 2019 3.00
Jun 30, 2019 1.00
Mar 31, 2019 10.00
Dec 31, 2018 2.00
Sep 30, 2018 -22.00
Jun 30, 2018 -34.00
Mar 31, 2018 336.00